Altogether, our findings demonstrate that peripheral blood CD45+CD33lowCD11bdim MDSCs suppress CD8+ T cell activity via the IL-6/IL-8-arginase I axis and are positively associated with GC tumor progression and negatively associated with overall patient survival. This evidence concerns the gene CD8A and neoplasm.